c-Abl Antibody (24-11)
  • c-Abl Antibody (24-11) is a mouse monoclonal IgG1 provided at 100 µg/ml
  • raised against a region within the c-Abl C-terminus domain
  • recommended for detection of c-Abl p120 and chimeric Bcr/Abl proteins in CML and ALL of mouse, rat and human origin by WB, IP, IF and ELISA

c-Abl Antibody (24-11): sc-23

c-Abl Antibody (24-11) is rated 4.0 out of 5 by 6.
  • 2016-09-29T11:41CST
  • bvseo_cps, prod_bvrr, vn_cps_3.4.0
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_6
  • loc_en_US, sid_23, PRD, sort_relevancy
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 110ms
  • REVIEWS, PRODUCT
Datasheets
    • c-Abl Antibody (24-11) is a mouse monoclonal IgG1 provided at 100 µg/ml
    • raised against a region within the c-Abl C-terminus domain
    • recommended for detection of c-Abl p120 and chimeric Bcr/Abl proteins in CML and ALL of mouse, rat and human origin by WB, IP, IF and ELISA
Conjugates

See c-Abl (8E9): sc-56887 for c-Abl antibody conjugates, including AC, HRP, FITC, PE, Alexa Fluor® 488 and Alexa Fluor® 647.

Ordering Information

PRODUCT NAME CATALOG # UNIT PRICE QTY FAVORITES
c-Abl Antibody (24-11) sc-23 100 µg/ml $279.00

You May Also Like

c-Abl Antibody (24-11) Product Citations

See how others have used c-Abl Antibody (24-11). Click on the entry to view the PubMed entry .

Citations 1 to 10 of 79 total

PMID: # 25450971
Bernusso, VA. et al. 2015. Imatinib restores VASP activity and its interaction with Zyxin in BCR-ABL leukemic cells. Biochimica et biophysica acta. 1853: 388-95.

PMID: # 24569990
Wie, SM. et al. 2014. Inhibiting tyrosine phosphorylation of protein kinase Cδ (PKCδ) protects the salivary gland from radiation damage. J. Biol. Chem.. 289: 10900-10908.

PMID: # 23894305
Liu, Y. et al. 2013. Low expression of miR-196b enhances the expression of BCR-ABL1 and HOXA9 oncogenes in chronic myeloid leukemogenesis. PLoS ONE. 8: e68442.

PMID: # 22665498
Wetzel, D.M. et al. 2012. The Abl and Arg kinases mediate distinct modes of phagocytosis and are required for maximal Leishmania infection. Molecular and cellular biology. 32: 3176-86.

PMID: # 21690296
Chen A et al. 2011. c-Abl-Mediated Tyrosine Phosphorylation of the T-bet DNA-Binding Domain Regulates CD4+ T-Cell Differentiation and Allergic Lung Inflammation. Mol Cell Biol. . 31: 3445-3456.

PMID: # 20717963
Chen, JY. et al. 2011. Bcr-Abl-induced tyrosine phosphorylation of Emi1 to stabilize Skp2 protein via inhibition of ubiquitination in chronic myeloid leukemia cells. J. Cell. Physiol.. 226: 407-413.

PMID: # 21386967
Vilas-Zornoza, A. et al. 2011. Frequent and simultaneous epigenetic inactivation of TP53 pathway genes in acute lymphoblastic leukemia. PLoS ONE. 6: -.

PMID: # 21569802
Machado-Neto, JA. et al. 2011. Knockdown of insulin receptor substrate 1 reduces proliferation and downregulates Akt/mTOR and MAPK pathways in K562 cells. Biochim. Biophys. Acta. 1813: 1404-1411.

PMID: # 21220747
Warsch, W. et al. 2011. High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia. Blood. 117: 3409-3420.

PMID: # 21402757
Schneider, S. et al. 2011. Complex cellular responses of Helicobacter pylori-colonized gastric adenocarcinoma cells. Infect. Immun.. 79: 2362-2371.

Citations 1 to 10 of 79 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 75ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 4 out of 5 by from Various publishable data in WB using human K562 Various publishable data in WB using human K562, transfected 293, MCF-7 and leukemia cell lines. -SCBT Publication Review
Date published: 2015-06-29
Rated 4 out of 5 by from Various publishable data in IP using human K562 Various publishable data in IP using human K562, HEL92.1.7, HL-60 and HEK293 cell lines. -SCBT Publication Review
Date published: 2015-02-21
Rated 4 out of 5 by from Various publishable data in IP using african Various publishable data in IP using african green monkey Cos-7 cell lines. -SCBT Publication Review
Date published: 2015-05-15
Rated 4 out of 5 by from Publishable data in CoIP using human HLMVEC Publishable data in CoIP using human HLMVEC, HPAEC cells -SCBT Publication Review
Date published: 2015-06-27
Rated 4 out of 5 by from Publishable data in EMSA using human primary Publishable data in EMSA using human primary cells -SCBT Publication Review
Date published: 2014-05-06
Rated 4 out of 5 by from Nice band seen in WB using RAW 264 Nice band seen in WB using RAW 264.7 whole cell lysates. -SCBT QC
Date published: 2015-03-13
  • 2016-09-29T11:41CST
  • bvseo_cps, prod_bvrr, vn_cps_3.4.0
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_6
  • loc_en_US, sid_23, PRD, sort_relevancy
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 5ms
  • REVIEWS, PRODUCT

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2016 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.